A
Ancha Baranova
Researcher at George Mason University
Publications - 290
Citations - 9793
Ancha Baranova is an academic researcher from George Mason University. The author has contributed to research in topics: Gene & Fatty liver. The author has an hindex of 38, co-authored 260 publications receiving 8146 citations. Previous affiliations of Ancha Baranova include Russian Academy & Florida State University College of Arts and Sciences.
Papers
More filters
Journal ArticleDOI
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
TL;DR: Aliment Pharmacol Ther 2011; 34: 274–285
Journal ArticleDOI
The mammalian pannexin family is homologous to the invertebrate innexin gap junction proteins.
Ancha Baranova,Dmitry Ivanov,Nadezda Petrash,Anya Pestova,Mikhail Skoblov,Ilya V. Kelmanson,Dmitry A. Shagin,Svetlana Nazarenko,Elena Geraymovych,Oxana Litvin,Anya Tiunova,Timothy L. Born,Natalia Usman,Dmitry B. Staroverov,Sergey Lukyanov,Yury Panchin +15 more
TL;DR: Cloned genes PANX1, PANX2 and PANX3, encoding putative gap junction proteins homologous to invertebrate innexins, which constitute a new family of mammalian proteins called pannexins are revealed, pointing to their important function.
Journal ArticleDOI
Adipokines and cytokines in non-alcoholic fatty liver disease
Mohammed Jarrar,Ancha Baranova,Ancha Baranova,Ancha Baranova,R. Collantes,Benjamin L. Ranard,Maria Stepanova,C. Bennett,Yun Fang,Hazem Elariny,Zachary Goodman,Vikas Chandhoke,Vikas Chandhoke,Zobair M. Younossi,Zobair M. Younossi,Zobair M. Younossi +15 more
TL;DR: A small number of adipocytokines have been implicated in the pathogenesis of non‐alcoholic fatty liver disease (NAFLD) and these drugs were found to have an anti-inflammatory effect on mice with NAFLD.
Journal ArticleDOI
A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).
Zobair M. Younossi,Zobair M. Younossi,Zobair M. Younossi,Mohammed Jarrar,Mohammed Jarrar,Clare Nugent,Clare Nugent,Manpreet Randhawa,Manpreet Randhawa,Mariam Afendy,Mariam Afendy,Maria Stepanova,Maria Stepanova,Nila Rafiq,Nila Rafiq,Zachary Goodman,Vikas Chandhoke,Vikas Chandhoke,Ancha Baranova,Ancha Baranova,Ancha Baranova +20 more
TL;DR: Four ELISA-based tests were combined to form a simple diagnostic biomarker for NASH and blinded validation of this model confirmed its reliability for separating NASH from simple steatosis.
Journal ArticleDOI
Non-Invasive markers for hepatic fibrosis
Ancha Baranova,Ancha Baranova,Priyanka Lal,Priyanka Lal,Aybike Birerdinc,Aybike Birerdinc,Zobair M. Younossi,Zobair M. Younossi +7 more
TL;DR: Use of non-invasive procedures could be recommended as pre-screening that may allow physicians to narrow down the patients' population before definitive testing of liver fibrosis by biopsy of the liver.